Glyceryl Monolinoleate

Glyceryl Monolinoleate

SCHEMBL154133

CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCC(O)CO

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.92
DGKA P23743 1/20 0.92
KDM4E B2RXH2 1/20 0.76
DUSP3 P51452 1/20 0.76
MEN1 O00255 1/20 0.76
KMT2A Q03164 1/20 0.76
LMNA P02545 1/20 0.76
SELP P16109 1/20 0.69
PRKCE Q02156 1/20 0.66
PRKCQ Q04759 1/20 0.66
PRKCD Q05655 1/20 0.66
PRKCA P17252 1/20 0.66
LPAR1 Q92633 5/20 0.65
ENPP2 Q13822 2/20 0.65
LPAR4 Q99677 2/20 0.65
LPAR5 Q9H1C0 2/20 0.65
LPAR2 Q9HBW0 2/20 0.65
LPAR3 Q9UBY5 2/20 0.65
CES2 O00748 1/20 0.65
LPAR6 P43657 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glyceryl Monolinoleate SCHEMBL29943084 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1
Glyceryl Monolinoleate SCHEMBL27565842 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1
Glyceryl Monolinoleate SCHEMBL29512923 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1
SCHEMBL29379264 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1
SCHEMBL29376457 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1
Glyceryl Monolinoleate SCHEMBL4350267 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1
Glyceryl Monolinoleate SCHEMBL8536841 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1
Glyceryl Monolinoleate SCHEMBL6371582 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1
Glyceryl Monolinoleate SCHEMBL19564919 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1
1-Monolinolein SCHEMBL4572646 1.00 FAAH (0.92) FAAHDGKAKDM4EDUSP3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8184 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104110-A1 FOAM CONDITIONER HENKEL AG & CO. KGAA (DE) 2026-05-21 WO claimed
US-20260137651-A1 MULTI-COMPARTMENT NANOEMULSION FOR INTRANASAL DRUG DELIVERY KING ABDULAZIZ UNIVERSITY (SA) 2026-05-21 US claimed
EP-4734959-A1 USE OF GLYCERIDES FOR LNP FORMULATIONS Sanofi Pasteur Inc. (US) 2026-05-06 EP claimed
US-20260115155-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN CHORDA PHARMA INC (US) 2026-04-30 US claimed
US-12605325-B2 Hair styling compositions for improving the elongation of hair curls L'OREAL (FR) 2026-04-21 US claimed
EP-4724081-A2 SOLID STATE FORMS OF RENCOFILSTAT Hepion Pharmaceuticals, Inc. (US) 2026-04-15 EP claimed
US-12599572-B2 Solid lipid nanoparticles of curcumin Punjab University Chandigarh (IN) 2026-04-14 US claimed
US-20260083756-A1 Capsules With Self-Emulsifying Drug Delivery Systems FERTIN PHARMA A/S (DK) 2026-03-26 US claimed
US-20260083757-A1 Dosage Forms For Delivery Of Self-Emulsifying Drug Delivery Systems FERTIN PHARMA A/S (DK) 2026-03-26 US claimed
US-20260076904-A1 NANO-PARTICLES OF MENAQUINONE-9 AND METHODS OF TREATMENT EPIZON INC (US) 2026-03-19 US claimed
US-5057500-A TREATMENT OF PRURITIS WITH ESTERS AND AMIDES DERMATOLOGIC RESEARCH CORPORATION (US) 1991-10-15 US claimed
WO-1991012010-A1 TREATMENT OF PRURITIS WITH ESTERS AND AMIDES DERMATOLOGIC RESEARCH CORPORATION (US) 1991-08-22 WO claimed
CN-2067828-U IMPULSE-RESISTANT PRESSURE GAGE HU YI (CN) 1990-12-19 CN claimed
WO-1990010441-A1 TREATMENT OF SKIN DISEASES AND TUMORS THORNFELDT CARL R (US) 1990-09-20 WO claimed
EP-0314689-A1 A CONTROLLED-RELEASE COMPOSITION FOR A BIOLOGICALLY ACTIVE MATERIAL DISSOLVED OR DISPERSED IN AN L2-PHASE. DRILLETTEN AB (SE) 1989-05-10 EP claimed
EP-0299937-A1 A composition based on phosphatidylcholine and medical uses thereof LARSSON, Kare (SE) 1989-01-18 EP claimed
EP-0126751-B1 METHOD OF PREPARING CONTROLLED-RELEASE PREPARATIONS FOR BIOLOGICALLY ACTIVE MATERIALS FLUIDCRYSTAL I MALMÖ AB (SE) 1988-05-04 EP claimed
WO-1988000059-A1 A CONTROLLED-RELEASE COMPOSITION FOR A BIOLOGICALLY ACTIVE MATERIAL DISSOLVED OR DISPERSED IN AN L2-PHASE DRILLETTEN AB (SE) 1988-01-14 WO claimed
EP-0104043-A2 Foodstuffs and pharmaceuticals AJINOMOTO CO., INC. (JP) 1984-03-28 EP claimed
US-4271196-A Pharmaceutical compositions for parenteral or local administration HOFFMANN-LA ROCHE INC. (US) 1981-06-02 US claimed